Education
About Us
Working with TipRanks
Follow Us
Todd Davis Insider Profile
4 Followers
Todd Davis, CEO, Director at Ligand Pharma, holds 1.50M shares in Pelthos Therapeutics (Ticker: PTHS), holds 161.47K shares in Ligand Pharma (Ticker: LGND), holds 125.91K shares in Vaxart (Ticker: VXRT). Most recently, Todd Davis Bought ― shares of Pelthos Therapeutics on Jul 03, 2025 for an estimated value of $15.00M.
Profitable Transactions
12 out of 13 Profitable Transactions
Average Return
+15.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Todd Davis holds in companies
Most Profitable Insider Trade
The most profitable trade made by Todd Davis
Todd Davis's Trading History
Ligand Pharma
Jul 02, 2025
CEO, Director
Uninformative Buy
21.22K
$27.40M
BioDelivery
Mar 22, 2022
―
Uninformative Sell
―
$0.00
Vaxart
Aug 08, 2022
Director
Uninformative Buy
―
$46.46K
Pelthos Therapeutics
Jul 03, 2025
Director
Informative Buy
15.00M
$50.80M
Palvella Therapeutics
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Todd Davis's performance on stock
You May Also Like
Todd Davis insider profile FAQ
What is the percentage of profitable transactions made by Todd Davis?
The percentage of profitable transactions made by Todd Davis is 92%.
What is the average return per transaction made by Todd Davis?
The average return per transaction made by Todd Davis is 15.90%.
What stocks does Todd Davis hold?
Todd Davis holds: LGND, BDSI, VXRT, PTHS, PVLA stocks.
What was Todd Davis’s latest transaction?
Todd Davis latest transaction was an Informative Buy of $15.00M.
What was Todd Davis's most profitable transaction?
Todd Davis’s most profitable transaction was an Informative Buy of PTHS stock on July 3, 2025. The return on the trade was 108.80%.
What is Todd Davis's role in Ligand Pharma?
Todd Davis's role in Ligand Pharma is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.